http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018214528-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3a9b48084b8620260beac95a10f7359
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_097405822d505467fd50f7100022cd56
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001129
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-54
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
filingDate 2018-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86f4091231eb23b2cb9e66d0b112d1c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34e981f8d26055279dc159e4feda0197
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7751d956bad54762482fa11e18b3167a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23dcdb2d2afceafbc20580d8f3378b1b
publicationDate 2018-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2018214528-A1
titleOfInvention Pharmaceutical composition for inhibiting expression of cd47 in tumor cells and use of same
abstract The pharmaceutical composition for inhibiting expression of CD47 in tumor cells provided by the present invention contains:n exosomes produced by cultured tumor cells in an amount effective for inhibiting expression of the CD47; and a pharmaceutically acceptable carrier.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021184022-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114958722-A
priorityDate 2017-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6685911-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018104187-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426146645
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9541
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID975
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6099081
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421462122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450100484
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID155774
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10029
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226445716
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24785025
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9541
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID967
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6452212
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID511435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536059
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100008988
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12512
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3397

Total number of triples: 45.